Ben Simons awarded grand prix Charles-Léopold Mayer 2023 by the French Académie des Sciences…
November 21, 2023Read more
Within our remit to study development and disease, groups at the Institute work on a diverse range of research areas. We also use several different model organisms and apply up-to-the-minute techniques in genetics, gene editing, organoids, imaging and computational analysis.
Find out about our range of research areas and which group leaders work in each area.
Our scientists publish 80+ papers each year in the top journals, many of which become highly cited as seminal findings in their field.
Our focus is fundamental biology, yet more than a dozen start-up companies have emerged from research at the Institute. Several new therapies are now being tested in clinical trials, including for myeloid leukemia.
The cancer drug Olaparib resulted from Steve Jackson’s research on DNA damage repair and is now licensed for use around the world, prolonging the lives of people with ovarian, breast and prostate cancer.